| Biologic Therapy |
1 |
1 |
| Biosimilars |
0 |
0.99 |
| Psoriatic Arthritis |
0 |
0.67 |
| Psoriasis |
0 |
0.56 |
| Rheumatoid Arthritis |
0 |
0.55 |
| Arthritis |
0 |
0.52 |
| Juvenile Rheumatoid Arthritis (JRA) |
0 |
0.52 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.49 |
| Sepsis |
0 |
0.39 |
| Otolaryngology |
0 |
0.21 |
| Pharmacokinetics |
0 |
0.21 |
| Plaque Psoriasis |
0 |
0.21 |
| Crohn Disease |
0 |
0.15 |
| Upper Respiratory Tract Infection |
0 |
0.15 |
| Ulcerative Colitis |
0 |
0.12 |
| Adverse Effects |
0 |
0.1 |
| Ankylosing Spondylitis |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Colitis |
0 |
0.1 |
| Lymphoma |
0 |
0.1 |
| Respiratory Tract Infections |
0 |
0.1 |
| Severity Index |
0 |
0.1 |
| Sinusitis |
0 |
0.1 |
| Tumor |
0 |
0.1 |
| Headache |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Inflammatory Bowel Disease |
0 |
0.09 |
| Patient Safety |
0 |
0.09 |
| Tuberculosis |
0 |
0.09 |